LI

LIONEX GMBH

Grant-FundedCORDIS

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

Visit website
🇩🇪 Braunschweig, Germany·lionex.de
Biotech · Deep Tech
LIONEX GMBH is a private SME recorded in CORDIS in Germany, with participation in 18 EU research and innovation projects. Its recorded projects include “A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€7,571,434
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇩🇪Germany
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics

Startup insights

Value proposition

LIONEX GMBH is a private SME recorded in CORDIS in Germany, with participation in 18 EU research and innovation projects. Its recorded projects include “A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.

BiotechDeep Tech
Tags:BiotechDeep Tech

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime
LIONEX GMBH — A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | EUACC